taurolidine has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, Z; Li, F; Qi, J; Qin, C; Ren, W | 1 |
1 other study(ies) available for taurolidine and cyclin d1
Article | Year |
---|---|
Taurolidine promotes cell apoptosis by enhancing GRIM‑19 expression in liver cancer.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin D1; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; NADH, NADPH Oxidoreductases; Proto-Oncogene Proteins c-bcl-2; STAT3 Transcription Factor; Taurine; Thiadiazines; Time Factors; Up-Regulation | 2018 |